NCT06793111 Visceral Leishmaniasis in Emilia-Romagna (Leishmania-2019)
| NCT ID | NCT06793111 |
| Status | Recruiting |
| Phase | — |
| Sponsor | IRCCS Azienda Ospedaliero-Universitaria di Bologna |
| Condition | Leishmaniasis, Visceral |
| Study Type | OBSERVATIONAL |
| Enrollment | 300 participants |
| Start Date | 2020-04-21 |
| Primary Completion | 2025-05-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 300 participants in total. It began in 2020-04-21 with a primary completion date of 2025-05-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
According to reports in the literature, from 2012 to date, there has been an increase in the number of diagnosed cases of autochthonous visceral Leishmania in the Province of Bologna. In this context, it was decided to carry out a retrospective prospective observational study, which is essential to describe the epidemiology of LV in order to outline the scientific and rational bases necessary for the drafting of guidelines to standardise the diagnostic and therapeutic approach to this disease, in order to reduce the diagnostic delay and improve therapeutic results. therapeutic outcome. In addition, epidemiological data will make it possible to identify possible new strategies to control the disease, which are essential for reducing its transmission.
Eligibility Criteria
Inclusion Criteria: * Patients of any age with microbiologically established diagnosis of LV. * Obtaining Informed Consent. Exclusion Criteria: * not having obtained Informed Consent
Contact & Investigator
Pierluigi Viale, MD
PRINCIPAL INVESTIGATOR
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Frequently Asked Questions
Who can join the NCT06793111 clinical trial?
This trial is open to participants of all sexes, aged 6 Years or older, up to 90 Years, studying Leishmaniasis, Visceral. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06793111 currently recruiting?
Yes, NCT06793111 is actively recruiting participants. Contact the research team at pierluigi.viale@unibo.it for enrollment information.
Where is the NCT06793111 trial being conducted?
This trial is being conducted at Cesena, Italy, Forlì, Italy, Bologna, Italy, Ravenna, Italy and 1 additional location.
Who is sponsoring the NCT06793111 clinical trial?
NCT06793111 is sponsored by IRCCS Azienda Ospedaliero-Universitaria di Bologna. The principal investigator is Pierluigi Viale, MD at IRCCS Azienda Ospedaliero-Universitaria di Bologna. The trial plans to enroll 300 participants.